Development of SARS-CoV-2 IgM and IgG antibodies in a relapsing multiple sclerosis patient on ofatumumab
Ramon Flores-Gonzalez, Jeffrey Hernandez, Leticia Tornes, Kottil Rammohan, Silvia Delgado
Topics & Concepts
MedicineOfatumumabMultiple sclerosisImmunologyAntibodyAsymptomaticCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyImmunoglobulin GMonoclonal antibodyInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders